Showing results (281-290 of 308) with videos related to
Sort By:
Pageof 31
Health Science Reports|August 24, 2022
Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohortSofia R Bartlett, Andrey Verich, Joanne Carson, et al.Antiviral Research|May 18, 2010
Biochemical characterization of the inhibition of the dengue virus RNA polymerase by beta-d-2'-ethynyl-7-deaza-adenosine triphosphateDerek R Latour, Andreas Jekle, Hassan Javanbakht, et al.European Journal of Gastroenterology & Hepatology|January 3, 2020
Cost effectiveness of treatment models of care for hepatitis C: the South Australian state-wide experienceJeyamani Ramachandran, Billingsley Kaambwa, Kate Muller, et al.The New England Journal of Medicine|August 2, 2023
Selective Inhibition of NaV1.8 with VX-548 for Acute PainJim Jones, Darin J Correll, Sandra M Lechner, et al.Journal of Hepatology|May 23, 2021
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infectionGail V Matthews, Sanjay Bhagani, Marc Van der Valk, et al.Frontiers in Veterinary Science|April 2, 2020
Molecular Characterization of Haemaphysalis Species and a Molecular Genetic Key for the Identification of Haemaphysalis of North AmericaAlec T Thompson, Kristen Dominguez, Christopher A Cleveland, et al.Hepatology (Baltimore, Md.)|November 21, 2017
Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failureFred Poordad, Stanislas Pol, Armen Asatryan, et al.International Journal of Toxicology|June 3, 2022
Increasing the Reuse of Protein Non-Naïve Nonhuman Primates in Pharmaceutical Drug Discovery and Development: An Overview and Industry Position on the Challenges and BenefitsCharles Mattis, Natalie Bratcher, Monika Burns, et al.Communications Chemistry|January 25, 2023
Spatial and temporal scales of variability for indoor air constituentsPascale S J Lakey, Youngbo Won, David Shaw, et al.The International Journal on Drug Policy|June 19, 2017
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE studyJason Grebely, Olav Dalgard, Evan B Cunningham, et al.Pageof 31